Galen platform receives FDA Breakthrough Device Designation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Ibex Medical Analytics Galen platform has received Breakthrough Device Designation from FDA.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login